Currently, The Female Health Company (FHC) is manufacturing its second-generation product, FC2, on four production lines in Malaysia. The company, in conjunction with its Indian partner, HLL Lifecare, currently produces FC2 on a fifth production line located in Kochi, India.
The approval by FDA permits sale of FC2 in the US and purchases by the US Agency for International Development for distribution in HIV/AIDS prevention programs throughout the world.
Mike Pope, vice president of UK and Malaysian operations, said: “The Malaysian production expansion will bring the total FC2 female condom manufacturing capacity to an annualized rate of approximately 85 million units by early in the fourth quarter of calendar year 2009.”